Tag - drugmaker

 
 

DRUGMAKER

Japan Times
BUSINESS / Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever.
BUSINESS / Companies
May 23, 2017
Deal for U.S. drugmaker Upsher-Smith Laboratories poised to boost sales for Sawai
For decades, the Sawai family was content to keep the drug business it founded focused on the Japanese market. Now, it is steering the country's second-biggest maker of generic drugs through its first overseas acquisition in its 88-year history.
Japan Times
BUSINESS / Companies
Mar 7, 2016
Drugmaker wins big in Japan as its gamble leads to landmark cancer drug
Ten years ago, representatives from Japan's Ono Pharmaceutical Co. went from hospital to hospital, attempting to convince doctors to test a new product under development: drugs that helped the body's immune system fight cancer. But nobody would listen.
BUSINESS / Companies
Feb 21, 2016
Japan's Sosei sees more tie-ups with international drugmakers in the pipeline
Japan's Sosei Group Corp., which has seen its stock triple over the past year on tie-ups with international companies, could enter into more partnerships in 2016 to develop new medicines and diversify beyond its main lung disease treatment.
Japan Times
BUSINESS / Companies
Sep 29, 2014
Daiichi Sankyo to buy Ambit to strengthen cancer product line
Daiichi Sankyo Co. has agreed to buy U.S.-based Ambit Biosciences Corp. for as much as $410 million to bolster its pipeline of cancer treatments.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?